Weekly Standard, February 25, 2008.
In his State of the Union address President Bush spoke briefly on matters of life and science. He stated his intention to expand funding for new possibilities in medical research, to take full advantage of recent breakthroughs in stem cell research that provide pluripotent stem cells without destroying nascent human life. At the same time, he continued, “we must also ensure that all life is treated with the dignity that it deserves. And so I call on Congress to pass legislation that bans unethical practices such as the buying, selling, patenting, or cloning of human life.”
As in his previous State of the Union addresses, the president’s call for a ban on human cloning was greeted by considerable applause from both sides of the aisle. But Congress has so far failed to pass any anti-cloning legislation, and unless a new approach is adopted, it will almost certainly fail again.
Fortunately, new developments in stem cell research suggest a route to effective and sensible anti-cloning legislation, exactly at a time when novel success in cloning human embryos makes such legislation urgent. Until now, the cloning debate has been hopelessly entangled with the stem cell debate, where the friends and the enemies of embryonic stem cell research have managed to produce a legislative stalemate on cloning. The new scientific findings make it feasible to disentangle these matters and thus to forge a successful legislative strategy. To see how this can work, we need first to review the past attempts and the reasons they failed.